Anti-doping news

PUBLIC DISCLOSURE

The ITA reports that it has asserted an ADRVs against Russian weightlifters Aslan Bideev (RUS) and Andrey Kozlov (RUS) under Article 2.1 (Presence of a Prohibited Substance or its Metabolites or Markers) and Article 2.2 (Use or Attempted Use by an Athlete of a Prohibited Substance or a Prohibited Method) of the IWF Anti-Doping Rules (IWF ADR). The Article 2.1 assertions are based on ITA’s re-analysis campaign on samples provided by the weightlifters during the 2012 IWF European Championships in Antalya, Turkey in April 2012. The samples had initially been reported as “negative” in 2012, but thanks to the improvements in the detection methods, the WADA-accredited laboratory of Cologne conducted further analysis in 2021 which revealed the presence of prohibited steroids. The Article 2.2 assertions are based on investigations conducted by WADA’s Intelligence and Investigation Department (WADA I&I) and by Professor Richard McLaren into allegations of systemic doping practices in Russian sport as well as Moscow Laboratory Information Management System (LIMS) data retrieved by WADA I&I over time. The evidence was provided by WADA I&I to the ITA in 2021 for further assessment. In particular, these investigations uncovered LIMS data indicative of the presence of banned substances in samples provided by Aslan Bideev in 2012 and 2013 and Andrey Kozlov in 2012. The athletes have been informed of the cases and have been provisionally suspended until the resolution of the matter. Pursuant to the IWF’s delegation of its anti-doping program to the ITA, the prosecution of the cases is being handled entirely by the ITA. Given that the cases are underway, there will be no further comments during the ongoing

PUBLIC DISCLOSURE

The International Testing Agency (ITA), leading an independent anti-doping program for the International Weightlifting Federation (IWF), asserts an Anti-Doping Rule Violation (ADRV) against Russian Weightlifter Kseniya Kozina for the use of prohibited substances based on data retrieved by the World Anti-Doping Agency (WADA) from the Moscow laboratory. The ITA reports that it has asserted an ADRV against Russian weightlifter Kseniya Kozina under Article 2.2 (Use or Attempted Use by an Athlete of a Prohibited Substance or a Prohibited Method) of the IWF Anti-Doping Rules (IWF ADR). The assertion is based on investigations conducted by the World Anti-Doping Agency’s Intelligence and Investigation Department (WADA I&I) and by Professor Richard McLaren into allegations of systemic doping practices in Russian sport as well as Moscow Laboratory Information Management System (LIMS) data retrieved by WADA I&I over time. The evidence was provided by WADA I&I to the ITA in 2021 for further assessment. In particular, these investigations uncovered LIMS data as well as underlying analytical data pertaining to a sample provided by Kseniya Kozina in 2014 which contained the prohibited anabolic agent Ostarine.  The athlete has been informed of the case and has been provisionally suspended until the resolution of the matter. Pursuant to the IWF’s delegation of its anti-doping program to the ITA, the prosecution of the case is being handled entirely by the ITA. Given that the case is underway, there will be no further comments during the ongoing

PUBLIC DISCLOSURE

The International Testing Agency (ITA), leading an independent anti-doping program for the International Weightlifting Federation (IWF), has notified German weightlifter Vicky Schlittig of an Apparent Anti-Doping Rule Violation. The ITA reports that a sample collected during an in-competition testing mission on 26 September 2021 during the 2021 European Junior Championships in Finland from Vicky Schlittig, a weightlifter from Germany, has returned an Adverse Analytical Finding (AAF) for the prohibited anabolic steroid dehydrochloromethyl-testosterone (DHCMT). The athlete has been informed of the case and has been provisionally suspended until the resolution of the matter. She has the right to request the analysis of the B-sample. Pursuant to the IWF’s delegation of its anti-doping program to the ITA, the prosecution of the case is being handled entirely by the ITA. Given that the case is underway, there will be no further comments during the ongoing

PUBLIC DISCLOSURE

THE INTERNATIONAL TESTING AGENCY (ITA) ASSERTS ANTI-DOPING RULE VIOLATIONS (ADRVS) AGAINST RUSSIAN WEIGHTLIFTER RODION BOCHKOV FOR THE PRESENCE AND USE OF PROHIBITED SUBSTANCES BASED ON MOSCOW LABORATORY DATA AND SUBSEQUENT ADVERSE ANALYTICAL FINDING. The ITA reports that it has asserted ADRVs against Russian weightlifter Rodion Bochkov under Article 2.2 (Use or Attempted Use by an Athlete of a Prohibited Substance or a Prohibited Method) and Article 2.1 (Presence of a Prohibited Substance or its Metabolites or Markers) of the International Weightlifting Federation Anti-Doping Rules (IWF ADR). The Article 2.2 assertion is based on investigations conducted by the World Anti-Doping Agency’s Intelligence and Investigation Department (WADA I&I) and by Professor Richard McLaren into allegations of systemic doping practices in Russian sport as well as Moscow Laboratory Information Management System (“LIMS”) data retrieved by WADA I&I over time. In particular, these investigations uncovered LIMS data as well as underlying analytical data pertaining to a sample provided by Mr Bochkov in 2012 and this evidence was provided by WADA I&I to the ITA in 2021 for further assessment. Accordingly, the ITA conducted further investigation and target testing, including the collection of a sample during an out-of-competition testing mission on 6 September 2021. The analysis of the sample revealed an Adverse Analytical Finding (AAF) for the prohibited steroid dehydrochloromethyl-testosterone metabolite (DHCMT). The athlete has been informed of the case and has been provisionally suspended until the resolution of the matter. He has the right to request the analysis of the B-sample. Pursuant to the IWF’s delegation of its anti-doping program to the ITA, the prosecution of the case is being handled entirely by the ITA. Given that the case is underway, there will be no further comments during the ongoing

PUBLIC DISCLOSURE

THE INTERNATIONAL TESTING AGENCY (ITA) REPORTS THAT A SAMPLE COLLECTED FROM BULGARIAN WEIGHTLIFTER YUNDER BEYTULA HAS RETURNED AN ADVERSE ANALYTICAL FINDING (AAF) FOR HUMAN GROWTH HORMONES (HGH) (S2. PEPTIDE HORMONES, GROWTH FACTORS). The ITA reports that a sample collected from Mr. Beytula during an out-of-competition testing mission on 1 July 2021 carried out in Bulgaria on behalf of the International Weightlifting Federation (IWF) has returned an Adverse Analytical Finding for prohibited Human Growth Hormones. The athlete has been notified of the case and the provisional suspension imposed against him on 10 June 2021 by the ITA based on an incident that occurred during an Out-Of-Competition testing mission on 29 December 2020 is maintained until the resolution of the matter. Mr. Beytula has the right to request the analysis of the B-sample. If confirmed, this will potentially be the athlete’s third ADRV as Mr Beytula was previously sanctioned with a period of ineligibility from 11 October 2013 until 11 October 2015 for the presence of prohibited anabolic steroids in a sample collected from him on 25 September 2013 and was charged by the ITA with additional anti-doping rule violations on 10 June 2021 as mentioned above. Should he not accept the consequences provided for under the IWF ADR, he will have the right to ask for a hearing. Pursuant to the IWF’s delegation of its anti-doping program to the ITA, the prosecution of this case is being handled entirely by the ITA. Given that the case is underway, there will be no further comments during the ongoing

PUBLIC DISCLOSURE

THE ITA ASSERTS RULE VIOLATIONS AGAINST BULGARIAN WEIGHTLIFTER YUNDER BEYTULA The International Testing Agency (ITA), leading an independent anti-doping program for the International Weightlifting Federation (IWF), asserts anti-doping rule violations against Bulgarian weightlifter Yunder Beytula. The ITA reports that based on an incident that occurred during an Out-Of-Competition testing mission conducted by the ITA on 29 December 2020, the ITA has charged Yunder Beytula with committing Anti-Doping Rule Violations (ADRVs). The ITA alleges that Mr. Beytula provided wrong whereabouts information to the ITA and then when located, refused to provide a sample during the abovementioned doping control. Mr. Beytula has thus been charged with committing violations of Article 2.3 (Evading and Refusing Sample Collection) and Article 2.5 (Tampering or Attempted Tampering with any part of Doping Control) of the IWF Anti-Doping Rules (IWF ADR). The athlete has been informed of the case and has been provisionally suspended until the resolution of the matter. If confirmed, this will potentially be the athlete’s second ADRV (the athlete was previously sanctioned with a period of ineligibility from 11 October 2013 until 11 October 2015 for the presence of prohibited anabolic steroids in a sample collected from him on 25 September 2013). Should he not accept the consequences provided for under the IWF ADR, he will have the right to ask for a hearing. Pursuant to the IWF’s delegation of its anti-doping program to the ITA, the prosecution of this case is being handled entirely by the ITA. Given that the case is underway, there will be no further comments during the ongoing